1980
DOI: 10.1016/s0021-9673(00)80082-5
|View full text |Cite
|
Sign up to set email alerts
|

Determination of clindamycin in pharmaceuticals by high-performance liquid chromatography using ion-pair formation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

1985
1985
2006
2006

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(5 citation statements)
references
References 3 publications
0
5
0
Order By: Relevance
“…Landis et al [8] separated clindamycin from relative compounds in pharmaceuticals on a C 18 analytical column and reported a positive correlation between ion-pair formation and the number of carbons in the alkylsulfonate molecule used as ion-pairing agent. La Follette et al [14] also used tetramethylammonium chloride and adjusted the pH of the mobile phase to 6.7.…”
Section: Chromatographymentioning
confidence: 99%
See 2 more Smart Citations
“…Landis et al [8] separated clindamycin from relative compounds in pharmaceuticals on a C 18 analytical column and reported a positive correlation between ion-pair formation and the number of carbons in the alkylsulfonate molecule used as ion-pairing agent. La Follette et al [14] also used tetramethylammonium chloride and adjusted the pH of the mobile phase to 6.7.…”
Section: Chromatographymentioning
confidence: 99%
“…The pH of the aqueous phase was adjusted to 3.5, which is relatively low compared to the pH used by the majority of other investigators [8,10,14,15], although Hornedo-Nuñez et al [9] successfully applied a mobile phase with a pH 2.5. Adjustment was performed with the use of 1 M ortho-phosphoric acid.…”
Section: Chromatographymentioning
confidence: 99%
See 1 more Smart Citation
“…[2] was found to be unsuitable for use with the new formulation, because triethyl citrate (a tablet excipient) and degradation product A (an impurity resulting from exposure of clindamycin to one of the excipients, This prompted a review of the literature, which showed that several HPLC methods have been developed over the years for clindamycin and clindamycin-related impurities [1][2][3][4][5][6][7][8]. Some of these relied upon ion-pair reagent in the mobile phase to effect the separation; therefore, they were not considered for this effort because of the inherent instability and long equilibration times often associated with such methods.…”
Section: Introductionmentioning
confidence: 99%
“…mentation; 7-epiclindamycin is produced during the synthesis of clindamycin [3]. The rapid identification and characterization of minor impurities is an important task.…”
Section: Introductionmentioning
confidence: 99%